European Union - English - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,

Australia - English - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 42411 - ventilator, adult - the bellavista ventilator was developed for ventilating adult and paediatric patients and, optionally, neonatal patients as of a tidal volume of ?2 ml1. the device is intended for use in clinics and institutional facilities where medically trained professionals are available for attending to the patient. the device can be used at the bedside, as well as for transferral within a facility, when a patient is in need of oxygen. bellavista is only intended for use by trained personnel under the supervision of a licensed doctor.

Singapore - English - HSA (Health Sciences Authority)

seqirus pte. ltd. - influenza virus (sh) a/california/07/2009 (h1n1) pdm09- like strain; influenza virus (sh) a/hong kong/4801/2014 (h3n2) - like strain; influenza virus (sh) b/brisbane/60/2008 - like strain - injection - 15 mcg ha/0.5ml - influenza virus (sh) a/california/07/2009 (h1n1) pdm09- like strain 15 mcg ha/0.5ml; influenza virus (sh) a/hong kong/4801/2014 (h3n2) - like strain 15 mcg ha/0.5ml; influenza virus (sh) b/brisbane/60/2008 - like strain 15 mcg ha/0.5ml

United States - English - NLM (National Library of Medicine)

fritz industries - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - common symptoms of parasitic diseases treated skin flukes: extra mucous, visible spots or worms, flashing, scratching or rubbing on rocks wasting disease : clamped fins, weight loss, lethargy, deformity gill flukes: discolored, swollen gills, rapid breathing, gasping at surface prazicleanse is a safe anti-parasitic treatment to control unwanted parasites. our easy-to-use packet dosing system is effective against skin and gill flukes, tapeworms, flatworms, and turbellarians. works in both fresh and saltwater systems without affecting biological filtration when used as directed. prazicleanse is safe for use with most invertebrates.

United States - English - NLM (National Library of Medicine)

novartis vaccines and diagnostics srl - neisseria meningitidis serogroup b nhba fusion protein antigen (unii: 28e911y7ae) (neisseria meningitidis serogroup b nhba fusion protein antigen - unii:28e911y7ae) - neisseria meningitidis serogroup b nhba fusion protein antigen 50 ug in 0.5 ml

United States - English - NLM (National Library of Medicine)

novartis vaccines and diagnostics s.r.l. - neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen (unii: 3o44u6xyqk) (neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen - unii:3o44u6xyqk) - neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug in 0.5 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

gsk vaccines s.r.l. - neisseria meningitidis c, corynebacterium diphtheriae crm197 carrier protein - pdr+solv for susp for inj - 10 microgram - meningococcal vaccines

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - influenza virus (nh) a/california/07/2009 (h1n1) - like strain - injection - >=15 mcg haemagglutinin/0.5 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

gsk vaccines s.r.l. - meningococcal group c oligosaccharide; corynebacterium diphtheriae crm197 protein - suspension for injection in pre-filled syringe - 10 - meningococcal vaccines; other meningococcal polyvalent purified polysaccharides antigen - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

United Kingdom - English - myHealthbox

novartis vaccines and diagnostics - neisseria meningitidis group c (strain c11) oligosaccharide, corynebacterium diphtheriae crm197 protein , adsorbed on aluminium - suspension for injection - 10micrograms, 12.5 to 25.0micrograms, 0.3 to 0.4mg al 3+ - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.